Sriram Venkataraman
CIK 1550642 · last filed 2023-01-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$732.10M
Companies
4
Total Filings
12
Lifetime Open-Market Net
-$112.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVL Pharmaceuticals plc (RVLP) Delisted | Director | 23,730,864 | $0.03 | $669.2K | $12.40M | 2 | 2023-01-30 |
| RVL Pharmaceuticals plc (OSMT) Delisted | Director | 1,032,995 | $1.11 | $1.15M | $6.25M | 2 | 2020-11-23 |
| OptiNose, Inc. (OPTN) Delisted | Director | 10,136,374 | $9.60 | $97.31M | -$71.59M | 6 | 2020-06-12 |
| LNTH | Director | 7,004,395 | $104.52 | $732.10M | -$59.10M | 2 | 2017-03-21 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-21 | LNTH | Sell (S) | −3,000,000 | -$36.60M | EDGAR |
| 2016-11-23 | LNTH | Sell (S) | −2,500,000 | -$22.50M | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.